uc003mhh.2

GCCCAGCACTCTCAGTGGGGAGCCAGGTGGGAGAACAGGCTCGGAAGGGGACCTAGGCTTATGCAGCGAGCCGGGCAAAGCTGGAACTGGAGCCCAGGCCCCTGGATGCCCCCTGGCTTGTGGAGTTCTGGGATACTGAGGGGAGGGGACAGGGCATGGGAGTGCGGTGCTCTCACCTTTGACTTGAACTCATTCCCCAGGGGACAGGGGAGGCCTCCTCAGGATCCACAGATGCCCAGTCTCCCAAGAG
................................................................................................................((((......((((((.((......((((.(((((.((...((((....)))).)).))))).))))...)).)))))).....))))..................................................
..............................................................................................................111......................................................................................200................................................

Size

Perfect hit

Total Norm

Perfect Norm

SRR189783

SRR189782

SRR387910(GSM843862)
antibody for ip: Ago2. (ago2 cell line)

DRR000558(DRX000316)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)

SRR060981(GSM569185)
Human centroblast [09-001]. (cell line)

SRR189784

SRR039191(GSM494810)
PBMCs were isolated by ficoll gradient from t. (blood)

SRR033725(GSM497070)
Unmutated CLL (CLLU626). (B cell)

SRR207115(GSM721077)
XRN1&2 knockdown. (XRN1/XRN2 cell line)

SRR060983(GSM569187)
Human pre-germinal center B cell [09-001]. (cell line)

SRR207110(GSM721072)
Nuclear RNA. (cell line)

DRR000561(DRX000319)
Isolation of RNA following immunoprecipitatio. (ago2 cell line)

DRR000556(DRX000314)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)

SRR033718(GSM497063)
Multiple Myeloma (U266). (B cell)

SRR060982(GSM569186)
Human centrocyte [09-001]. (cell line)

SRR037941(GSM510479)
293DroshaTN. (cell line)

TAX577579(Rovira)
total RNA. (breast)

RoviraIPAgo2(Rovira)
total RNA. (ago2 breast)

DRR000555(DRX000313)
"THP-1 whole cell RNA, no treatment". (cell line)

SRR039620(GSM531983)
HBV(+) Adjacent Tissue Sample 2. (liver)

SRR060984(GSM569188)
Human plasma cell [09-001]. (cell line)

SRR015360(GSM380325)
Plasma B cells (PC137). (B cell)

SRR330921(SRX091759)
tissue: normal skindisease state: normal. (skin)

SRR033719(GSM497064)
6hr Activated B cell line (ABC158). (B cell)

SRR330865(SRX091703)
tissue: skin psoriatic involveddisease state:. (skin)

GSM450606(GSM450606)
miRNA sequencing raw reads from post-mortem s. (brain)

SRR330905(SRX091743)
tissue: normal skindisease state: normal. (skin)

GSM1105748AGO1(GSM1105748)
small RNA sequencing data. (ago1 hela)

SRR037936(GSM510474)
293cand1. (cell line)

SRR330873(SRX091711)
tissue: skin psoriatic involveddisease state:. (skin)

SRR330908(SRX091746)
tissue: normal skindisease state: normal. (skin)

SRR107297(GSM677704)
18-30nt fraction of small RNA. (cell line)

TAX577588(Rovira)
total RNA. (breast)

DRR000562(DRX000320)
Isolation of RNA following immunoprecipitatio. (ago3 cell line)

SRR039615(GSM531978)
Severe Chronic Hepatitis B Liver Tissue. (liver)

SRR039625(GSM531988)
HBV(-) HCV(-) HCC Tissue Sample. (liver)

SRR191613(GSM715723)
66genomic small RNA (size selected RNA from t. (breast)

SRR553575(SRX182781)
source: Kidney. (Kidney)

SRR207111(GSM721073)
Whole cell RNA. (cell line)

SRR189787

GSM450604(GSM450604)
miRNA sequencing raw reads from post-mortem s. (brain)

DRR000557(DRX000315)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)

SRR444058(SRX128906)
Sample 16cDNABarcode: AF-PP-335: ACG CTC TTC . (skin)

SRR191407(GSM715517)
81genomic small RNA (size selected RNA from t. (breast)

SRR060985(GSM569189)
Human naive B cell [09-001]. (cell line)

SRR553573(SRX182779)
source: Cerebellum. (Cerebellum)

TAX577741(Rovira)
total RNA. (breast)

GSM1105749AGO2(GSM1105749)
small RNA sequencing data. (ago2 hela)

SRR330899(SRX091737)
tissue: skin psoriatic uninvolveddisease stat. (skin)

SRR444057(SRX128905)
Sample 15cDNABarcode: AF-PP-334: ACG CTC TTC . (skin)

SRR039193(GSM494812)
HL60 cell line is derived from acute promyelo. (cell line)

SRR033720(GSM497065)
EBV activated B cell line (EBV159). (B cell)

SRR039635(GSM518472)
THP1_nuc_sRNAs. (cell line)

DRR000559(DRX000317)
"THP-1 whole cell RNA, no treatment". (cell line)

SRR033713(GSM497058)
Burkitt Lymphoma (BL115). (B cell)

SRR553576(SRX182782)
source: Testis. (testes)

GSM1105750AGO3(GSM1105750)
small RNA sequencing data. (ago3 hela)

SRR330858(SRX091696)
tissue: skin psoriatic involveddisease state:. (skin)

SRR330915(SRX091753)
tissue: normal skindisease state: normal. (skin)

SRR326282(GSM769512)
"Dicer mRNA was knocked down using siDicer, t. (cell line)

SRR363673(GSM830250)
cell type: human foreskin fibroblasts (HFF)tr. (fibroblast)

SRR342897(SRX096793)
small RNA seq of Left atrial tissue. (heart)

SRR330866(SRX091704)
tissue: skin psoriatic involveddisease state:. (skin)

SRR330878(SRX091716)
tissue: skin psoriatic involveddisease state:. (skin)

SRR342896(SRX096792)
small RNA seq of Right atrial tissue. (heart)

SRR330916(SRX091754)
tissue: normal skindisease state: normal. (skin)

SRR039623(GSM531986)
HCV(+) HCC Tissue Sample. (liver)

SRR330895(SRX091733)
tissue: skin psoriatic uninvolveddisease stat. (skin)

SRR330859(SRX091697)
tissue: skin psoriatic involveddisease state:. (skin)

SRR330902(SRX091740)
tissue: skin psoriatic uninvolveddisease stat. (skin)

SRR330872(SRX091710)
tissue: skin psoriatic involveddisease state:. (skin)

.................................................................................................................................................................................TTTGACTTGAACTCATTCCCCAGT.................................................

42.00

14.00

4.00

1.00

2.00

4.00

1.00

2.00

3.00

2.00

1.00

3.00

1.00

2.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAGT.................................................

16.00

10.00

1.00

4.00

1.00

14.00

2.00

3.00

1.00

2.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAG..................................................

10.00

7.00

3.00

.....................................................................................................................................................................................................CAGGGGACAGGGGAGGGCTA.................................

8.00

0.00

3.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAGA.................................................

8.00

10.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAGAA................................................

5.00

10.00

2.00

1.00

2.00

5.00

14.00

1.00

.....................................................................................................................................................................................................CAGGGGACAGGGGAGGGC...................................

4.00

0.00

1.00

..............................GAGAACAGGCTCGGAAG...........................................................................................................................................................................................................

4.00

......................................GCTCGGAAGGGGACCTAGGCTTATGCA.........................................................................................................................................................................................

3.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAGTA................................................

2.00

10.00

1.00

.................................................................................................................................................................................TTTGACTTGAACTCATTCCCCAT..................................................

2.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAGG.................................................

2.00

1.00

............................................................................................................................................................................TCACCTTTGACTTGATCC............................................................

2.00

0.00

2.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAA..................................................

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAAG.................................................

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCA...................................................

1.00

.....................................................................................................................................................................................................CAGGGGACAGGGGAGGCCTA.................................

1.00

0.00

1.00

..................................................................................................................................................................TGCGGTGCTCTCACCGCCG.....................................................................

1.00

0.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAGAGT...............................................

1.00

10.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCC....................................................

1.00

...................................................................................................................GCTTGTGGAGTTCTGCGG.....................................................................................................................

1.00

0.00

1.00

.................................................................................................................................................................GTGCGGTGCTCTCACATTA......................................................................

1.00

0.00

1.00

14.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAAT.................................................

1.00

.................................................................................................................................................................................TTTGACTTGAACTCATTCCCCA...................................................

1.00

.........................................................................................................................................GAGGGGAGGGGACAGGGCAGGGG..........................................................................................

1.00

0.00

1.00

.................................................................................................................................................................................TTTGACTTGAACTCATTCCCC....................................................

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAGTAG...............................................

1.00

10.00

1.00

..........................................................................................................................................AGGGGAGGGGACAGGGCATGGG..........................................................................................

1.00

.................................................................................................................................................GGGACAGGGCATGGGAGGCAG....................................................................................

1.00

0.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAT..................................................

1.00

...................................................................................................................................................................................TGACTTGAACTCATTCCCCAGAGAA..............................................

1.00

0.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCATT.................................................

1.00

.................................................................................................................................................................................TTTGACTTGAACTCATTCCCCAA..................................................

1.00

14.00

1.00

14.00

1.00

.................................................................................................................................................................................TTTGACTTGAACTCATTCCCTAA..................................................

1.00

0.00

1.00

.....................................................................................................................................................................................................CAGGGGACAGGGGAGGC....................................

0.67

0.50

0.17

GCCCAGCACTCTCAGTGGGGAGCCAGGTGGGAGAACAGGCTCGGAAGGGGACCTAGGCTTATGCAGCGAGCCGGGCAAAGCTGGAACTGGAGCCCAGGCCCCTGGATGCCCCCTGGCTTGTGGAGTTCTGGGATACTGAGGGGAGGGGACAGGGCATGGGAGTGCGGTGCTCTCACCTTTGACTTGAACTCATTCCCCAGGGGACAGGGGAGGCCTCCTCAGGATCCACAGATGCCCAGTCTCCCAAGAG ................................................................................................................((((......((((((.((......((((.(((((.((...((((....)))).)).))))).))))...)).)))))).....)))).................................................. ..............................................................................................................111......................................................................................200................................................	Size	Total Norm	SRR189783	SRR189782	SRR387910(GSM843862) antibody for ip: Ago2. (ago2 cell line)	DRR000558(DRX000316) "THP-1 whole cell RNA, after 3 day treatment . (cell line)	SRR060981(GSM569185) Human centroblast [09-001]. (cell line)	SRR189784	SRR039191(GSM494810) PBMCs were isolated by ficoll gradient from t. (blood)	SRR033725(GSM497070) Unmutated CLL (CLLU626). (B cell)	SRR207115(GSM721077) XRN1&2 knockdown. (XRN1/XRN2 cell line)	SRR060983(GSM569187) Human pre-germinal center B cell [09-001]. (cell line)	SRR207110(GSM721072) Nuclear RNA. (cell line)	DRR000561(DRX000319) Isolation of RNA following immunoprecipitatio. (ago2 cell line)	DRR000556(DRX000314) "THP-1 whole cell RNA, after 3 day treatment . (cell line)	SRR033718(GSM497063) Multiple Myeloma (U266). (B cell)	SRR060982(GSM569186) Human centrocyte [09-001]. (cell line)	SRR037941(GSM510479) 293DroshaTN. (cell line)	TAX577579(Rovira) total RNA. (breast)	RoviraIPAgo2(Rovira) total RNA. (ago2 breast)	DRR000555(DRX000313) "THP-1 whole cell RNA, no treatment". (cell line)	SRR039620(GSM531983) HBV(+) Adjacent Tissue Sample 2. (liver)	SRR060984(GSM569188) Human plasma cell [09-001]. (cell line)	SRR015360(GSM380325) Plasma B cells (PC137). (B cell)	SRR330921(SRX091759) tissue: normal skindisease state: normal. (skin)	SRR033719(GSM497064) 6hr Activated B cell line (ABC158). (B cell)	SRR330865(SRX091703) tissue: skin psoriatic involveddisease state:. (skin)	GSM450606(GSM450606) miRNA sequencing raw reads from post-mortem s. (brain)	SRR330905(SRX091743) tissue: normal skindisease state: normal. (skin)	GSM1105748AGO1(GSM1105748) small RNA sequencing data. (ago1 hela)	SRR037936(GSM510474) 293cand1. (cell line)	SRR330873(SRX091711) tissue: skin psoriatic involveddisease state:. (skin)	SRR330908(SRX091746) tissue: normal skindisease state: normal. (skin)	SRR107297(GSM677704) 18-30nt fraction of small RNA. (cell line)	TAX577588(Rovira) total RNA. (breast)	DRR000562(DRX000320) Isolation of RNA following immunoprecipitatio. (ago3 cell line)	SRR039615(GSM531978) Severe Chronic Hepatitis B Liver Tissue. (liver)	SRR039625(GSM531988) HBV(-) HCV(-) HCC Tissue Sample. (liver)	SRR191613(GSM715723) 66genomic small RNA (size selected RNA from t. (breast)	SRR553575(SRX182781) source: Kidney. (Kidney)	SRR207111(GSM721073) Whole cell RNA. (cell line)	SRR189787	GSM450604(GSM450604) miRNA sequencing raw reads from post-mortem s. (brain)	DRR000557(DRX000315) "THP-1 whole cell RNA, after 3 day treatment . (cell line)	SRR444058(SRX128906) Sample 16cDNABarcode: AF-PP-335: ACG CTC TTC . (skin)	SRR191407(GSM715517) 81genomic small RNA (size selected RNA from t. (breast)	SRR060985(GSM569189) Human naive B cell [09-001]. (cell line)	SRR553573(SRX182779) source: Cerebellum. (Cerebellum)	TAX577741(Rovira) total RNA. (breast)	GSM1105749AGO2(GSM1105749) small RNA sequencing data. (ago2 hela)	SRR330899(SRX091737) tissue: skin psoriatic uninvolveddisease stat. (skin)	SRR444057(SRX128905) Sample 15cDNABarcode: AF-PP-334: ACG CTC TTC . (skin)	SRR039193(GSM494812) HL60 cell line is derived from acute promyelo. (cell line)	SRR033720(GSM497065) EBV activated B cell line (EBV159). (B cell)	SRR039635(GSM518472) THP1_nuc_sRNAs. (cell line)	DRR000559(DRX000317) "THP-1 whole cell RNA, no treatment". (cell line)	SRR033713(GSM497058) Burkitt Lymphoma (BL115). (B cell)	SRR553576(SRX182782) source: Testis. (testes)	GSM1105750AGO3(GSM1105750) small RNA sequencing data. (ago3 hela)	SRR330858(SRX091696) tissue: skin psoriatic involveddisease state:. (skin)	SRR330915(SRX091753) tissue: normal skindisease state: normal. (skin)	SRR326282(GSM769512) "Dicer mRNA was knocked down using siDicer, t. (cell line)	SRR363673(GSM830250) cell type: human foreskin fibroblasts (HFF)tr. (fibroblast)	SRR342897(SRX096793) small RNA seq of Left atrial tissue. (heart)	SRR330866(SRX091704) tissue: skin psoriatic involveddisease state:. (skin)	SRR330878(SRX091716) tissue: skin psoriatic involveddisease state:. (skin)	SRR342896(SRX096792) small RNA seq of Right atrial tissue. (heart)	SRR330916(SRX091754) tissue: normal skindisease state: normal. (skin)	SRR039623(GSM531986) HCV(+) HCC Tissue Sample. (liver)	SRR330895(SRX091733) tissue: skin psoriatic uninvolveddisease stat. (skin)	SRR330859(SRX091697) tissue: skin psoriatic involveddisease state:. (skin)	SRR330902(SRX091740) tissue: skin psoriatic uninvolveddisease stat. (skin)	SRR330872(SRX091710) tissue: skin psoriatic involveddisease state:. (skin)
............................GGGAGAACAGGCTCGGATCTT.........................................................................................................................................................................................................	21	1.00	-	-	-	-	-	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
..........................................................................................................................GAGTTCTGGGATACTGTG..............................................................................................................	18	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	-	-	-	-	-	-	-	-	-
.........................................................................................................................................................................................GAACTCATTCCCCAGTGAT..............................................	19	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-